SCHEMBL5032073

SCHEMBL5032073

Cc1cnccc1C(=O)Nc1ccc(-c2sc(-c3ncco3)cc2C)cn1

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ABCB1 P08183 2/20 0.39
ABCC1 P33527 2/20 0.39
IL2 P60568 2/20 0.38
NPC1 O15118 5/20 0.36
RAB9A P51151 5/20 0.36
MCL1 Q07820 2/20 0.36
ALOX15 P16050 1/20 0.36
HTT P42858 1/20 0.36
TP53 P04637 1/20 0.36
MAPK1 P28482 1/20 0.36
ALDH1A1 P00352 1/20 0.35
IKBKE Q14164 2/20 0.35
TBK1 Q9UHD2 2/20 0.35
WNT3A P56704 2/20 0.35
PORCN Q9H237 1/20 0.34
PKM P14618 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
SORT1 Q99523 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5435249 0.92 RAB9A (0.41) ABCB1ABCC1IL2NPC1RAB9A
SCHEMBL5032094 0.92 IL2 (0.44) ABCB1ABCC1IL2NPC1RAB9A
SCHEMBL5032088 0.89 MCL1 (0.41) IL2NPC1RAB9AMCL1HTT
SCHEMBL5029467 0.87 ABCB1 (0.38) ABCB1ABCC1IL2NPC1RAB9A
SCHEMBL5030734 0.85 ABCB1 (0.39) ABCB1ABCC1IL2NPC1RAB9A
SCHEMBL8228068 0.84 IL2 (0.45) ABCB1IL2NPC1RAB9ATP53
SCHEMBL5033884 0.84 IL2 (0.49) IL2NPC1RAB9AALDH1A1WNT3A
SCHEMBL5115802 0.83 NPC1 (0.41) ABCB1ABCC1IL2NPC1RAB9A
SCHEMBL2815541 0.82 IL2 (0.46) ABCB1ABCC1IL2NPC1RAB9A
SCHEMBL5032016 0.82 IL2 (0.57) IL2NPC1RAB9ATP53ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1983831-A2 PHENYL AND PYRIDYL COMPOUNDS FOR INFLAMMATION AND IMMUNE-RELATED USES Synta Pharmaceuticals Corporation (US) 2008-10-29 EP claimed
US-20070275960-A1 Phenyl and pyridyl compounds for inflammation and immune-related uses SYNTA PHARMACEUTICALS CORP. (US) 2007-11-29 US claimed
WO-2007087429-A2 PHENYL AND PYRIDYL COMPOUNDS FOR INFLAMMATION AND IMMUNE-RELATED USES SYNTA PHARMACEUTICALS CORP. (US) 2007-08-02 WO claimed
EP-1983831-A2 PHENYL AND PYRIDYL COMPOUNDS FOR INFLAMMATION AND IMMUNE-RELATED USES Synta Pharmaceuticals Corporation (US) 2008-10-29 EP disclosed
US-20070275960-A1 Phenyl and pyridyl compounds for inflammation and immune-related uses SYNTA PHARMACEUTICALS CORP. (US) 2007-11-29 US disclosed
US-20070275960-A1 Phenyl and pyridyl compounds for inflammation and immune-related uses SYNTA PHARMACEUTICALS CORP. (US) 2007-11-29 US disclosed
US-20070275960-A1 Phenyl and pyridyl compounds for inflammation and immune-related uses SYNTA PHARMACEUTICALS CORP. (US) 2007-11-29 US disclosed
WO-2007087429-A2 PHENYL AND PYRIDYL COMPOUNDS FOR INFLAMMATION AND IMMUNE-RELATED USES SYNTA PHARMACEUTICALS CORP. (US) 2007-08-02 WO disclosed
WO-2007087429-A2 PHENYL AND PYRIDYL COMPOUNDS FOR INFLAMMATION AND IMMUNE-RELATED USES SYNTA PHARMACEUTICALS CORP. (US) 2007-08-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070275960-A1 Phenyl and pyridyl compounds for inflammation and immune-related uses NLRP3, CCR1, NLRP1 ABCB1 436/4885ABCC1 343/4885IL2 55/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.